Vasculitis
|
0.200 |
Biomarker
|
disease |
BEFREE |
A monogenic autoinflammatory disease with fatal vasculitis: deficiency of adenosine deaminase 2.
|
31599797 |
2020 |
Vasculitis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The coding exons of ADA2 were sequenced in 60 children and adolescents with a diagnosis of PAN, cutaneous PAN, or unclassifiable vasculitis (UCV), any chronic vasculitis with onset at age 5 years or younger, or history of stroke.
|
31008556 |
2019 |
Vasculitis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Human adenosine deaminase type 2 deficiency (DADA2), due to biallelic deleterious mutations in the ADA2 gene, is the first described monogenic type of small- and medium-size vessel vasculitis.
|
30565235 |
2019 |
Vasculitis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Reduction of adenosine deaminase 2 (ADA2) activity due to autosomal-recessive loss-of-function mutations in the <i>ADA2</i> gene (previously known as <i>CECR1</i>) results in a systemic vasculitis known as deficiency of ADA2 (DADA2).
|
31015188 |
2019 |
Vasculitis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Until the diagnosis of DADA2 was confirmed, five patients have been followed-up with the diagnosis of PAN: two patients both with PAN and FMF, and one patient with CAPS and vasculitis.
|
28516235 |
2018 |
Vasculitis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis.
|
29271561 |
2018 |
Vasculitis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Deficiency of adenosine deaminase 2 (ADA2) due to homozygous or compound heterozygous mutations in the cat eye syndrome chromosome region, candidate 1 (<i>CECR1</i>) gene causes an autoimmune phenotype with systemic vasculitis affecting the skin, inner organs, and the central nervous system.
|
28024309 |
2017 |
Vasculitis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In childhood, beside inflammation lanced by ischemia itself, the event of ischemia might be provoked by an underlying inflammatory pathophysiology: transient focal arteriopathy, dissection, sickle cell anemia, Moyamoya and more generalized in meningitides, generalized vasculitis or genetic arteriopathies (as in ADA2).
|
29103427 |
2017 |
Vasculitis
|
0.200 |
Biomarker
|
disease |
BEFREE |
We sought to investigate the mechanisms of chronic inflammation and vasculitis in a child lacking IL-17RA and ADA2 to identify therapeutic targets.
|
26607704 |
2016 |
Vasculitis
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
These associations include ERAP1, CCR1-CCR3, STAT4, KLRC4, GIMAP4, and TNFAIP3 in Behçet's disease; BLK and CD40 in Kawasaki disease; SERPINA1 and SEMA6A in antineutrophil cytoplasmic antibody associated vasculitides; IL12B and FCGR2A/ FCGR2A in Takayasu arteritis; and CECR1 in a newly defined vascular inflammatory syndrome associated with adenosine deaminase (ADA2) deficiency.
|
25405820 |
2015 |
Vasculitis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Loss-of-function mutations in CECR1 were associated with a spectrum of vascular and inflammatory phenotypes, ranging from early-onset recurrent stroke to systemic vasculopathy or vasculitis.
|
24552284 |
2014 |
Vasculitis
|
0.200 |
Biomarker
|
disease |
HPO |
|
|
|